Tuomas Heikkinen Selected Research

Tuomas Heikkinen Research Topics

Disease

26	Breast Neoplasms (Breast Cancer) 04/2015 - 12/2008
17	Neoplasms (Cancer) 02/2016 - 02/2006
5	Leiomyoma (Uterine Fibroids) 09/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 08/2013 - 07/2011
2	Carcinogenesis 08/2013 - 01/2011
2	Endometrial Neoplasms (Endometrial Cancer) 07/2010 - 02/2006
1	Adenomyoma 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Intellectual Disability (Idiocy) 02/2016
1	alpha-Thalassemia 02/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Fibroadenoma 01/2016
1	Hereditary leiomyomatosis and renal cell cancer 01/2016
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 10/2012
1	Ovarian Epithelial Carcinoma 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2011
1	Fanconi Anemia (Fanconi's Anemia) 04/2011
1	Oculocutaneous albinism type 2 05/2010

Drug/Important Bio-Agent (IBA)

13	Estrogen ReceptorsIBA 01/2014 - 05/2009
9	Proteins (Proteins, Gene)FDA Link 02/2016 - 02/2006
6	Progesterone Receptors (Progesterone Receptor)IBA 08/2013 - 05/2009
5	Estrogens (Estrogen)FDA Link 08/2013 - 05/2009
4	Genetic Markers (Genetic Marker)IBA 05/2013 - 09/2009
4	Hormones (Hormone)IBA 02/2011 - 05/2010
3	Formaldehyde (Formol)FDA Link 12/2020 - 09/2012
3	ParaffinIBA 12/2020 - 09/2012
3	Mediator ComplexIBA 01/2018 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 05/2010
2	Fumarate Hydratase (Fumarase)IBA 01/2018 - 01/2016
2	Nonsense Codon (Nonsense Mutation)IBA 01/2017 - 02/2016
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 09/2009
2	MicroRNAs (MicroRNA)IBA 01/2014 - 06/2011
2	AnthracyclinesIBA 08/2013 - 09/2012
2	Keratins (Keratin)IBA 09/2012 - 05/2010
2	AndrogensIBA 04/2011 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 09/2009
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2022
1	Cullin Proteins (Cullins)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 12/2020
1	HMGA2 ProteinIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	X-linked Nuclear ProteinIBA 02/2016
1	Cyclin CIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2016
1	Leucine (L-Leucine)FDA Link 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2014
1	Eukaryotic Initiation Factor-4EIBA 08/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2013
1	A-Form DNA (A-DNA)IBA 09/2012
1	Methotrexate (Mexate)FDA LinkGeneric 09/2012
1	P 11 (P-11)IBA 09/2012
1	human ERBB2 proteinIBA 12/2011
1	GlycodelinIBA 07/2011
1	Tumor Biomarkers (Tumor Markers)IBA 02/2011
1	P-2 (P 2)IBA 02/2011
1	Cyclin EIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 05/2010
1	Epidermal Growth Factor (EGF)IBA 05/2010
1	OligonucleotidesIBA 05/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	Carrier Proteins (Binding Protein)IBA 09/2009
1	ORALIT (ORS)IBA 05/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2015 - 09/2012
3	Therapeutics 05/2013 - 05/2010
2	Adjuvant Chemotherapy 04/2015 - 08/2013
1	Radiotherapy 10/2013
1	Palliative Care (Palliative Therapy) 09/2012